Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
SNY similar filings
- 31 Jan 23 Current report (foreign)
- 17 Jan 23 Dupixent 300 mg weekly showed significant histological disease remission and improvement in symptoms of the disease compared to placebo
- 20 Dec 22 Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis
- 2 Dec 22 Positive Phase II/III study results support acoziborole’s potential in treatment for deadly disease
- 21 Nov 22 European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease
- 15 Nov 22 Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission
- 10 Nov 22 European Commission grants first approval worldwide of Beyfortus® (nirsevimab) for prevention of RSV disease in infants
Filing view
External links